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Abstract
An in-depth molecular study of infectious bronchitis viruses (IBV) with particular interest in evolutionary aspects of IBV in Spain was carried
out in the present study based on the S1 gene molecular characterization of twenty-six Spanish strains isolated over a fourteen-year period. Four
genotypes were identified based on S1 gene sequence analyses and phylogenetic studies. A drastic virus population shift was demonstrated along
time and the novel Italy 02 serotype was shown to have displaced the previous predominant serotype 4/91 in the field. Detailed analyses of
synonymous to non-synonymous ratio of the S1 gene sequences of this new serotype Italy 02 suggested positive selection pressures might have
contributed to the successful establishment of Italy 02 serotype in our country. In addition, differences on the fitness abilities of new emergent
genotypes were indicated. Furthermore, intergenic sequences (IGs)-like motifs within S1 gene sequences of IBV isolates were suggested to
enhance the recombination abilities of certain serotypes.
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SequencingIntroduction
Avian infectious bronchitis virus (IBV) is considered one of
the major poultry pathogens, being probably endemic in all
regions with intensive poultry production (Office, 2004). It is
primarily a respiratory pathogen of domestic fowl, although
strains can vary in pathogenicity and tissue tropism (Jones and
Ambali, 1987; Jones and Jordan, 1970; Winterfield and Hitchner,
1962). IBV is a Group 3 member in the genus Coronavirus
(Gonzalez et al., 2003) and its genome consists of a 27 Kb single-
stranded positive-sense RNA molecule that encodes for four
structural proteins. The nucleoprotein (N) is associated with viral
genome to form the nucleocapsid, whereas the remaining struc-⁎ Corresponding author. Centre de Recerca en Sanitat Animal (CReSA),
Edifici CReSA, Campus de la Universitat Autònoma de Barcelona, 08193
Bellaterra (Barcelona), Spain. Fax: +34 93 5814490.
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doi:10.1016/j.virol.2007.12.020tural proteins, the spike (S), small membrane (M), and envelope
proteins (E), are inserted in the envelope surrounding the nucleo-
capsid. In addition, the genome also encodes for the replicase
complex responsible for carrying out the unique discontinuous
transcription process that leads to the generation of a nested set
of six 3′ and 5′ coterminal subgenomic mRNAs (Stern and
Kennedy, 1980; Stern and Sefton, 1982).
The continuous emergence of new IBV serotypes has
complicated the design of appropriate control programs due to
the antigenic variation and the low degree of cross protection
observed among IBV serotypes and has pointed out the
necessity for accurate techniques to diagnose and classify this
viral agent (Cowen and Hitchner, 1975). Nucleotide sequencing
and subsequent genetic analysis of the S1 protein gene
sequences provides a fast and accurate method to classify and
predict IBV serotype, but also a powerful instrument to monitor
phylogenetic and epidemiological evolution of IBV subtypes
(Adzhar et al., 1997; Cavanagh and Davis, 1986; Cavanagh
et al., 1992b, 1986; Kant et al., 1992; Koch et al., 1990; Lee and
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et al., 1998; Wang and Huang, 2000). Mutation and recom-
bination processes have been demonstrated to be involved in the
genetic variation, and therefore in the evolution of IBV, leading
to the emergence of new variant strains and giving rise to virus
population diversity (Cavanagh et al., 1992a; Kottier et al.,
1995; Lee and Jackwood, 2000; Wang et al., 1997). However,
very distinct spatiotemporal and epidemiological behaviours are
shown among these new strains. Whereas some emergent
viruses rapidly spread to other geographic areas and become
established, as happened with the 4/91 serotype in Europe or the
Georgia serotype in North America, others remain restricted to
the region of origin. More interestingly, hardly ever genotypes
are exchanged among different continents (Kusters et al., 1987;
Zanella et al., 2003). Nevertheless, factors that determine
distinct spreading and fitness abilities of the new emergent
strains are poorly understood. Hence, monitoring IBV sub-
population dynamics in a specific region over time may reveal
molecular features that contributed to the different fitting and
spreading abilities of IBV strains.
IBV has been diagnosed in Spain since the early seventies by
virus isolation and serological techniques. In 2002, an epide-
miological survey among the most important Spanish poultry
companies pointed out IB as one of the main infectious diseases
affecting farms and revealed the necessity of an in-depth study
to determine the epidemiological situation and to improve the
efficacy of vaccination and control programs against the dis-
ease. Furthermore, the availability of IBV strains isolated in
Spain during the past 14 years provided a unique opportunity
for a detailed genetic study to determine not only the prevalent
IBV genotypes in our country but also the dynamics of viral
subpopulation which is necessary for a deeply understanding of
IBV evolution and epidemiology.
In this study, twenty-six IB viruses isolated in Spain from
clinical outbreaks occurring between 1992 and 2005 were
molecularly characterized by sequencing the whole S1 gene. To
increase our insight into factors involved in IBV evolutionary
process, specific tests to determine the presence of positive
selection forces were carried out. Furthermore, several methods
were implemented to identify putative recombination events
among these isolates and establish the extent of recombination into
IBV evolution. Finally, the antigenic relationships of the major
genotypes identified in our country with reference strains were
assessed by cross VN assays to ascertain the practical implications
of molecular changes observed into virus immunogenicity.
Results
S1 gene phylogenetic and sequence analyses revealed that four
different genotypes have been present in Spain over the last
14 years
Phylogenetic analysis based on both S1 gene nucleotide and
amino acid deduced sequences of the twenty-six Spanish
isolates and the reference IBV strains showed that Spanish
isolates were separated into four distinct genetic groups or
genotypes (Fig. 1). Genotype I included thirteen out of thetwenty-six field isolates, isolated between 1992 and 2000, that
were grouped with 4/91 reference isolates. Seven Spanish field
isolates, from 1997 to 2005, were included in genotype II, and
showed maximum nucleotide and amino acid identities with
Italy 02 strains. Genotype III comprised three field viruses
isolated between 1996 and 2000 that were grouped with isolates
of the Massachusetts serotype. Particularly, Spain/98/308 and
Spain/00/339 isolates were grouped with Massachusetts vaccine
strains (H120) in the phylogenetic tree, and they are likely to be
reisolations of vaccine strains used in the immunization of those
flocks. Finally, Spanish genotype IV included 3 isolates that
split in a unique genetic group in the phylogenetic analysis. All
viruses included in genotype IV were isolated in 1999 and
showed maximum nucleotide and amino acid identities with
Italy 02 isolates (90.6–92% and 89–91.1% respectively).
Genetic studies of Spanish isolates of 4/91 genotype (genotype I)
showed the presence of two distinct genetic clusters
The 13 isolates assigned into the Spanish genotype I group
shared maximum nucleotide and amino acid divergences of
7.3% and 10.3% respectively. Phylogenetic analyses comparing
the complete S1 gene sequences of the 13 Spanish genotype I
field isolates and all 4/91 S1 gene sequences previously
published in the GenBank database, including British, French
and Iranian isolates, revealed that Spanish isolates were clearly
grouped in two separated genetic clusters identified as Spanish
genotype I cluster 1 (including 11 isolates) and Spanish
genotype I cluster 2 (including 2 isolates). Average nucleotide
and amino acid identities shared by both clusters were 93.1%
and 91.3% respectively. The minimum amino acid divergence
observed between two isolates from the same year was 0.4%
(between Spain/92/185 and Spain/92/51), whereas the max-
imum was 9.9% (between Spain/99/319 and Spain/99/327).
Both cluster 1 and cluster 2 isolates showed maximum average
nucleotide and amino acid identities with French isolate FR-
94047-94. Comparison of 4/91 Spanish field isolates sequences
revealed a common unique deletion at amino acid position 58
(located in HVR1) in 6 isolates included in cluster 1. Four
isolates within this same group shared an amino acid deletion at
position 340, located in HVR3. Both isolates included in cluster
2 showed 8 unique amino acid substitutions. In addition, isolate
Spain/99/327 in cluster 2 showed 3 amino acid deletions at
positions 55, 56 and 57 (located in HVR1). No cumulative
changes were observed among 4/91 Spanish isolates.
Sequence analysis of Spanish isolates of Italy 02 genotype
(Genotype II) clearly revealed presence of cumulative amino
acid changes within S1 gene
A total of 11 Spanish field strains of Italy 02 genotype, seven
from the present study and 4 previously described (Dolz et al.,
2006), and the reference strain Italy 02 were included in the
present study. Maximum nucleotide and amino acid divergence
within Spanish Italy 02 isolates was 5.7% and 9.9%, respec-
tively. The maximum amino acid distance between two viruses
isolated the same year was 3.6% (Spain/04/5438 and Spain/04/
Fig. 1. Phylogenetic tree constructed by a maximum likelihood method (Tree-Puzzle 5.2). Nucleotide sequences of the complete S1 gene of Spanish field isolates
investigated in this study (in bold letters) and reference IBV strains obtained from GenBank database are included in the comparison.
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sequences of the Spanish Italy 02 isolates, except for the Spain/
98/313 that showed two deletions at amino acid positions 139
and 140. Analysis of the sequences showed that 12 amino acid
positions were cumulative changes that become fixed in a
progressive manner through time of isolation.Sequence analysis of Spanish genotype IV (Spain/99/325)
showed a drastic shift on sequence homology when 5′ and
3′ ends of S1 gene were compared
S1 gene sequences of genotype IV isolates were aligned and
compared with the remainder Spanish field isolates and a total of
Fig. 2. Entropy rates and non-synonymous and synonymous difference (dN−dS) plotted per each amino acid position for the first 150 amino acids of the S1 gene. Both
values were calculated using an alignment that included all Spanish field isolates of Italy 02 genotype.
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isolates with respect to Spanish 4/91, Italy 02 and Massachusetts
strains. Each mutated residue was compared with the residue
present in the same amino acid position in the other 3 Spanish
genotypes. Mutated positions were mostly shared with 4/91 and
Italy 02 strains, but distinct sharing rateswere observed between the
5′ and 3′ regions within the S1 gene. A total of 58 mutated residues
were identified within the 200 amino acid 5′ terminal region. OnlyFig. 3. Phylogenetic analysis of putative recombinant breakpoint located at position 58
were included in the comparison. Trees were generated by the Maximum Parsimon
obtained when the S1 region from nt 1 to 586 in the alignment was used. Italy 02
phylogenetic group. 3b. Phylogenetic tree obtained when the S1 region from nt 586
grouped with Spanish 4/91 cluster 1 isolates, whereas Spanish Italy 02 isolates form1 (1.7%) out of the 58 mutated residues within this region was
shared with 4/91 strains alone, whereas 33 (56.9%) were shared
with Italy 02 isolates. The remaining positions were predominantly
shared simultaneously with 4/91 and Italy 02 isolates. Very few
uniquemutations, 2 out of 58, were observed.When the 341 amino
acid 3′ terminal region was analysed, 28 (87.5%) out of 32
identified mutated positions coincided with residues of 4/91
isolates, whereas only 1 (3.1%) coincided with Italy 02 isolates.6 of Italy 02 and Genotype IV isolates. All twenty-six Spanish IBV field isolates
y method with 1000 bootstraps in the Mega 3 package. 3a. Phylogenetic tree
and Genotype IV (in bold letters) isolates were clustered together in the same
to 1623 in the alignment was used. Genotype IV isolates (in bold letters) were
ed an own phylogenetic cluster.
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tities observed when both regions were compared separately
among the three genotypes. Genotype IV had maximum amino
acid identities with Italy 02 Spanish genotype (87.3%–95.4%)
when the S1 200 Aa 5′ terminal region was compared, whereas
amino acid identities in the same region with 4/91 Spanish
genotype was much lower (68.8%–75.8%). On the contrary,
when the 341 Aa 3′ end of the S1 gene was compared, genotype
IV showed maximum amino acid identities with 4/91 Spanish
isolates (92.9%–97.9%), and lower similarities with Italy 02
Spanish isolates (88.8%–91.2%).
Positive selection pressure is detected in several amino acid
positions within Italy 02 isolates, particularly within epitope
region 2
The average dS/dN ratio within the 13 Spanish isolates of the
4/91 genotype was estimated to be 3.43, whereas within the
Italy 02 Spanish isolates was 1.97. To identify regions or
specific positions within the S1 gene under positive selection,
the dN−dS difference per codon was calculated for the Spanish
Italy 02 isolates. The resulting graphic of the dN−dS difference
plotted against entropy values for the initial 150 amino acid
positions of Spanish Italy 02 isolates is shown in Fig. 2. Clearly,
amino acid positions with positive dN−dS values also showedFig. 4. Phylogenetic analysis of putative recombinant breakpoint located at position 7
were included in the comparison. Trees were generated by the Maximum Parsimon
obtained when the S1 region from nt 1 to 700 in the alignment was used. Spanish 4/91
isolates. 4b. Phylogenetic tree obtained when the S1 region from nt 700 to 1623 in
clustered in an own phylogenetic branch closely related with Spanish Italy 02 isolatpositive entropy values and were predominantly located within
regions previously identified as virus-neutralizing and hemag-
glutination-inhibiting epitopes. Epitope 1 region contained 9
amino acid positions with positive dN−dS values, and five out
of these 9 positions (amino acid residues 37, 42, 60, 62 and 63)
were also fixed amino acid substitutions. Epitope 2 region
contained 18 amino acid positions with positive dN−dS values,
and five of them (residues 92, 129, 131, 141 and 143) became
also fixed amino acid positions.
Putative recombination events have been detected in three out
of the four IBV genotypes in Spain
A total of seven recombination events, including 16 recom-
bination breakpoints, were identified among Spanish IBV field
isolates. One recombination event, beginning at nucleotide 702
and ending at nucleotide 1389, was identified in both isolates of
Spanish 4/91 genotype cluster II by five methods. A total of five
recombination events were detected within Spanish Italy 02
isolates, however just only one of the six events was common to
the 11 isolates. It began at nucleotide position 583 and ended at
position 930, and it was detected by 5 out of the six methods
implemented. Finally, one recombination event, beginning at
nucleotide position 281 and ending at position 586, was detected
in all three isolates of Spanish genotype IV by 4 of the 6 methods00 of Spanish 4791 cluster 2 isolates. All twenty-six Spanish IBV field isolates
y method with 1000 bootstraps in the Mega 3 package. 4a. Phylogenetic tree
cluster 2 isolates (in bold letters) were grouped with the remaining Spanish 4/91
the alignment was used. Spanish 4/91 cluster 2 isolates (in bold letters) were
es.
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region comprised within recombination event and the remainder
sequence regions generated different tree topologies in all three
recombination events described (Fig. 3).
Cross-over sites were not homogeneously distributed within
S1 gene sequences. Eleven out of 16 breakpoints identified
within S1 gene sequences of Spanish field isolates were con-
centrated in the half 5′ terminal region. Particularly two regions
comprised between 100 and 200 nucleotide positions and 400
and 600 nucleotide positions concentrated 7 out of the 16 cross-
over sites. Thus, detailed sequence analysis of these regions
among all Spanish isolates was carried out to identify sequence
motifs, particularly IBV intergenic sequences (IGs) CTTAACA
and CTTAACAA, which might have facilitated RNA–RNA
recombination. All Spanish isolates included within genotype
IVand Italy 02 genotypes showed IGs CTTAACA twice within
S1 gene, at nucleotide positions 370 and 445, with the exception
of Spanish isolate Spain/05/21 that only showed it once at
nucleotide position 445. Any of the Spanish isolates of 4/91
genotype neither Massachusetts genotype included this motif
within S1 gene sequence. Nucleotide sequence CTTAACAA
was only found in genotype IV isolates and two Italy 02 isolates,
Spain/97/314 and Spain/98/313, between nucleotide positions
440 and 450. Any of the other Spanish isolates had this motif
within S1 gene sequences.Table 1
Epidemiologic information of Spanish field IBV isolates included in the study
IBV isolate a Year b Location Type of chicken
Spain/92/35 1992 N/A Broiler
Spain/92/51 1992 N/A Broiler
Spain/92/185 1992 N/A Broiler
Spain/95/193 1995 N/A Broiler
Spain/95/194 1995 N/A Broiler
Spain/96/312 1996 Catalunya Broiler
Spain/96/330 1996 Galicia Broiler
Spain/96/334 1996 N/A N/A
Spain/97/307 1997 Catalunya Broiler
Spain/98/308 1998 Valencia Slow growth
Spain/98/315 1998 Valencia Broiler
Spain/98/328 1998 N/A N/A
Spain/99/316 1999 Center Broiler
Spain/99/319 1999 Catalunya Slow growth
Spain/99/325 1999 Center Broiler
Spain/99/326 1999 Center Broiler
Spain/99/327 1999 Catalunya Broiler
Spain/00/336 2000 Catalunya Broiler
Spain/00/339 2000 Catalunya Broiler
Spain/02/26 2002 Navarra Broiler
Spain/04/22 2004 Catalunya Broiler
Spain/04/24 2004 Catalunya Broiler
Spain/04/221 2004 C. Mancha N/A
Spain/04/5438 2004 Catalunya Broiler
Spain/05/82 2005 C. Mancha N/A
Spain/05/866 2005 Murcia Broiler
Isolates are sorted by year of isolation and then by isolate number. The GenBank ac
N/A = Data not available.
a Isolates have been named as proposed by Cavanagh (2002).
b Year of isolation.
c Tissues used for IBV isolation.Antigenic relatedness studies of the field isolates Spain/99/319
and Spain/99/325
To further serologically characterize Spanish IBV isolates,
two Spanish field isolates Spain/99/319 and Spain/99/325
included in genotype 1 cluster 1 and genotype 4 respectively
were selected to assess VN assay Fig. 4. Antigenic relatedness
and neutralizing indexes are summarized in Table 2.
Discussion
Since it was first described in the early nineties in UK, 4/91
IBV serotype spread over many other countries and became one
of the most predominant serotypes in Europe (Capua et al.,
1999; Cavanagh et al., 2005; Cook et al., 1996; Gough et al.,
1992; Meulemans et al., 2001). The present study shows 4/91 as
one of the most predominant genotypes also in Spain and
demonstrates it has been circulating in our country since 1992.
Previous studies of the degree of variation exhibited within the
S1 gene sequences of 4/91 serotype isolates reported maximum
nucleotide and amino acid differences of 4% and 8%
respectively (Cavanagh et al., 2005). In the present investiga-
tion, 4/91 Spanish isolates showed higher genetic divergences
among them, and more interestingly they were split in two
major phylogenetic clusters, suggesting that 4/91 genotype hasAge Tissue c Accession numbers
N/A Trachea DQ386091
N/A Trachea DQ064801
N/A Trachea DQ386092
N/A Trachea DQ386093
N/A Trachea DQ064802
55d Trachea DQk064803
32d Trachea, kidney DQ386094
N/A Trachea DQ064804
43d Trachea DQ064805
35d Trachea DQ064807
35d Trachea, kidney, cecal tonsil DQ386095
N/A Trachea, kidney DQ386096
23d Kidney DQ064809
38d Trachea, cecal tonsil DQ064810
40d Kidney DQ064811
40d Kidney DQ064812
49d Trachea DQ386097
44d Trachea DQ386098
35d Trachea DQ064815
47d N/A DQ386099
49d Trachea DQ386100
36d Trachea DQ386101
N/A N/A DQ386103
49d Trachea DQ386105
N/A N/A DQ386104
41d Trachea DQ386102
cession number of the obtained S1 genes sequences for each isolate is included.
Table 2
Neutralizing index and antigenic relatedness of Spanish field isolates Spain/99/
319 (Genotype I) and Spain/99/325 (Genotype IV) field isolates and the main
reference IBV European serotypes
Virus 1 Virus 2 Neutralizing
index virus 1 a
Neutralizing
index virus 2 b
Antigenic
relatedness (%)
Spain/99/
325 c
M41 0.6 0.6 23.2
D274 0.84 0.6 33.0
D1466 0.6 0.6 24.3
4/91 0.8 0.6 26.3
Spain/00/337 e 2.8 1.98 67.5
Spain/99/319 0.8 1.7 47.3
Spain/99/325 2.9 2.9 100.0
Spain/99/
319 d
M41 0.6 0.6 27.3
D274 1.2 0.6 46.3
D1466 0.84 0.6 33.8
4/91 3 0.6 59.8
Spain/00/337 1.4 1.2 43.6
Spain/99/325 1.7 0.8 47.3
Spain/99/319 2.1 2.1 100.0
Maximumantigenic relatedness obtained for each isolate is indicated in bold letters.
a Neutralizing index obtained from antisera of virus 1 against virus 2.
b Neatruazing index obtained from antisera of virus 2 against virus 1.
c Spanish isolate representative from Genotype IV.
d Spanish isolate representative from Genotype I (4/91 Spanish isolate).
e Spanish field isolate previously demonstrated to belong to Italy 02 serotype
(Dolz et al., 2006).
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our country. Furthermore, cross VN results carried out with a
field 4/91 Spanish isolate demonstrates that these unique evo-
lutive processes contributed to greatly decrease the antigenic
relatedness between the 4/91 Spanish field strains and the
reference 4/91 serotype. Hence, these findings suggest that
antigenic subtypes may be present in field and in the brink of
arising as a new serotype, regardless of the level of genetic
variation displayed.
It is particularly remarkable that two Spanish 4/91 strains
isolated the same year practically showed the maximum
divergence exhibited within one IBV genotype and furthermore,
they were grouped in separate phylogenetic clusters. Although a
very rapid evolutive rate from a common ancestor might have
lead to a similar situation, no cumulative changes were observed
among Spanish 4/91 isolates and unique amino acidic changes
observed in one of these two groups were not shared by the
other. Moreover, the average dS/dN ratio for the whole S1 gene
was not suggestive of a high evolutive rate. Therefore, one
possible explanation for this scenario would be that 4/91 strains
isolated in Spain evolved from at least two distinct evolutive
lineages probably originated in two different ancestors. Taking
into account that both isolates assigned to Spanish 4/91 cluster 2
are the more recently isolated, a new reintroduction of 4/91
isolates in our country could be hypothesized as has been
previously suspected in other countries (Adzhar et al., 1997).
On the other hand, based on the results of recombination
analyses carried out in this study, the possibility that recom-
bination processes might have been involved in the rapid
evolution of the Spanish 4/91 cluster 2 giving rise to a new
lineage cannot be excluded.Interestingly, the present study also shows an important
shift in virus subpopulation dynamics along time with a clear
replacement of predominant genotypes in our country. Whereas
4/91 was the predominant genotype in Spain in the nineties, the
situation took a turn at the end of that decade when the new Italy
02 genotype appeared and displaced the previous predominant
genotype. High sequence divergences and the presence of
cumulative changes observed within Spanish Italy 02 isolates
further support a fast evolutionary rate of this serotype in our
country. A wide variety of causes could have been driving the
observed virus subpopulation replacement. However, we found
strong evidences of the positive selection of mutations within
the S1 epitope regions of Italy 02 isolates which suggest a
selection pressure-driven evolution of this genotype in Spain.
Evidently, some cautionary remarks should be considered as our
analyses were only focused on the S1 protein gene, but selection
pressures could have occurred in other regions within IBV
genome. Therefore, to accurately discern the evolutionary his-
tory of this genotypic shift, whole genome studies should be
carried out.
At this point an intriguing question comes out regarding
factors contributing to create a positive selection pressure. Our
data suggests positive selected mutations of Italy 02 might have
lead these new isolates escaping the immune system. Evidences
of positive selection pressures acting over specific residues
within antigenic sites have been previously reported for other
viruses against which partial cross protection is induced after
infection or vaccination, similarly to what happens with IBV
(Grenfell et al., 2004; Haydon et al., 2001; Hurst, 2002). In this
sense, it is noteworthy that at the late nineties, commercial
vaccines against the 4/91 became available in Spain. Therefore,
it is likely that vaccination implemented against 4/91 serotype
was very successful in order to achieve an effective control of
infections caused by this serotype in our country, based on the
drastic reduction of 4/91 isolations from clinical cases. But on
the other hand, it is tempting to speculate that the high immune
pressure against 4/91 isolates might have provided an environ-
ment in which the novel variant genotype Italy 02 had higher
fitness advantage contributing to a faster establishment and
spreading of this serotype in Spain.
Another challenging aspect of IBVepidemiology in Spain is
the emergence of the Genotype IV isolates and its relationship
with Italy 02 genotype. Genotype IV was established as a new
genotype based on the mosaic nature of its S1 gene. VN studies
revealed Italy 02 and Genotype IV as being subtypes within a
common serotype. However, the restricted epidemiological
relevance of genotype IV, all three isolates included within this
genotype were isolated in 1999 and in the same geographic
region, clearly indicates distinct fitness abilities among IBV
isolates. Therefore, this finding demonstrates that new unknown
IBV isolates are emerging constantly, but only those with
advantageous features within a particular environment become
established, whereas others disappear and remain unidentified.
The extent of recombination events among IBV field isolates
has been poorly investigated, even though recombination is a
well-known feature of IBV (Cavanagh et al., 1992a; Kottier
et al., 1995; Lee and Jackwood, 2000). Our data suggests that
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the evolution of IBV rather than sporadically. Interestingly,
most of the recombinant breakpoints identified among Spanish
IBV field isolates were clustered in restricted regions within the
5′ half part of the S1 gene and involved Italy 02 isolates,
suggesting the presence of sequence or structure motifs that
could act as specific “hotspots”. RNA sequences and structures
that promote viral RNA recombination have been demonstrated
in several viruses (Carpenter et al., 1995; Nagy and Bujarski,
1997). Particularly, IGs that are required for transcription acting
as a slow-down and detaching signal for the transcription–
replication complex have been speculated to promote recombi-
nation exchange of whole genes in IBV (Brian and Spaan, 1997;
Enjuanes et al., 2005; Lee and Jackwood, 2000). Based in our
results, “IGs-like” motifs, that probably arose because random
mutations, could have favoured recombination within specific
sites in the S1 gene, increasing the potential of Italy 02 genotype
to undergo recombination processes.
There have been few scientific studies covering the genetic
and antigenic variation within IBV serotypes and dynamics
along time of IBV genotypes in a specific region (Cavanagh
et al., 2005; Lee and Jackwood, 2001; Liu et al., 2006; Mase
et al., 2004). Herein, we present one of the most comprehensive
studies of the genetic variation and evolution within a popu-
lation of IBV isolates. Molecular analyses have revealed that
vaccination, despite greatly contributes to the control of specific
genotypes, may create and advantageous environment leading
to successful spreading of new genotypes. Furthermore, our
results indicate that recombination might have been frequently
involved in the emergence and evolution of IBV.
Materials and methods
Viruses and antisera
Twenty-six field avian IBVs isolated between 1992 and 2005
in Spain were included in this study. Viruses were obtained from
clinical cases submitted to Centre de Recerca en Sanitat Animal
(CReSA), Centre de Sanitat Avícola de Catalunya i Aragó
(CESAC) and Centro de Investigación en Sanidad Animal
(CISA). Epidemiological information of these isolates is sum-
marized in Table 1. All field viruses were isolated in specific
pathogen-free (SPF) embryonated eggs, acquired from Charles
Rivers Spafas (North Franklin, USA). Two commercial
vaccines currently licensed for use in Spain, IB 4/91 and IB
MA5, were also included in the study. The reference IBV
serotypes M41, D274, D1466 and 4/91 and antisera against
them to be used in the virus neutralization (VN) assay were
purchased from the Animal Health Center (Deventer, The
Netherlands). The Spanish field virus Spain/00/337, also used
in the VN assay, had been previously isolated and characterized
as belonging to the Italy 02 serotype in our laboratory (Dolz et
al., 2006). To obtain virus stocks for VN assays, allantoic fluid
from field isolates Spain/99/319 and Spain/99/325 and
reference strains was harvested, frozen at −80 C and then
titrated in SPF chicken embryos. Endpoint dilutions and titres
were determined by the Reed and Muench method (Villegas,1998). Monospecific antisera against field isolates were
obtained following the procedure previously described (Dolz
et al., 2006; Gelb and Jackwood, 1998).
RT-PCR and nucleotide sequencing
RNA was extracted from 150 μl of allantoic fluid using
Nucleospin RNA Virus Kit (Macherey-Nagel) according to
manufacturer's instructions. The complete S1 gene was am-
plified with oligonucleotides S1Uni2+ and IBP1- as previously
described (Adzhar et al., 1996). The 1800-bp RT-PCR products
were purified by QIAquick gel extraction Kit and Minelute PCR
purification Kit (Qiagen Inc.) following manufacturer's instruc-
tions. Sequencing of the whole S1 gene was carried out using a
combination of eight internal primers previously published
(Dolz et al., 2006). Some modifications were implemented to
primers S1PR2+, S1PR2–, S1PR5+ and S1PR6+ because sev-
eral mismatches were detected in some isolates, preventing cor-
rect sequencing. Sequences of modified primers were S1PR2+
nou (5′ TAGCCTACTTTGTTAATGGTA 3′), S1PR2–nou
(5′ GTACCATTAACAAAGTAGGCTA 3′), S1PR5+nou (5′
TAGATACTTCAGGAGCCATAGACA 3′) and S1PR6+nou
(5′ CCATAGACATATTTGTTGTTC 3′). Purified RT-PCR
products were sequenced by the dideoxy-mediated chain-
termination method using ABI PRISM BigDye® Terminator
v3.1 Cycle Sequencing Kit (PE Biosystems) as described by the
manufacturer. Sequences were analyzed with an automated
nucleic acid analyzer (ABI PRISM 3100 Avant; PE Biosystems).
Nucleotide and amino acid deduced sequence analyses
Assembly of sequence contigs and sequence analysis were
performed with the Bioedit v7.0.5 package. The twenty-six IBV
Spanish field isolates, the two vaccine strains, and the reference
IBV strains downloaded from the GenBank database were first
aligned using ClustalW included in the Bioedit v7.0.5. Phylo-
genetic trees were inferred using a maximum likelihood (ML)
algorithm with the Tree-Puzzle 5.2 software (Schmidt et al.,
2002). In all cases trees were estimated using the best fitting
model of nucleotide substitution identified by Modeltest 3.8
(Posada and Crandall, 1998).
GenBank accession numbers
Nucleotide and amino acid deduced S1 sequences of reference
IBV strains included in the comparisonswere available inGenBank
under the following accession numbers: Ark-99 (L10384);
Beaudette (X02342); B1648 (X87238); De072 (U77298); D1466
(M21971); D207 (M21969); D274 (X15832); D3896 (X52084);
FR-CR88061-88 (AJ618986); FR-85131-85 (AJ618985); FR-
96047-94 (AJ818987); Gray (L14069); Holte (L18988); H120
(M21970); H52 (AF352315); Italy 02 (AJ457137); IR-1061-PH
(AY544778); IR-1062-GA (AY544777); IR-3654-VM
(AY544776); JMK (L14070); M41 (X04722); Spain/97/314
(DQ064806); Spain/98/313 (DQ064808); Spain/00/337
(DQ064813) and Spain/00/338 (DQ064814); UK/2/91 (Z83976);
UK/3/91 (Z83977); UK/5/91 (Z83978); UK/7/91 (Z83975);
58 R. Dolz et al. / Virology 374 (2008) 50–59UK/7/93 (Z83979); UK-1233-95 (AJ618984); 4/91 pathogenic
(AF093794).
Selection pressure analysis on the S1 gene
Potential selective pressures along the S1 gene of major
Spanish genotypes isolates were assessed first by calculating the
average ratio of synonymous substitutions per synonymous site
(dS) to non-synonymous substitutions per non-synonymous site
(dN) (dS/dN). In addition, to detect specific residues within the S1
gene under strong selective pressure the subtraction of syno-
nymous from non-synonymous nucleotide changes (dN−dS) per
codon was calculated and plotted versus the amino acid se-
quence entropy, that is a measure of the lack of predictability at
each position in the alignment and gives an idea of the amount of
variability through a column in the alignment (Schneider and
Stephens, 1990). Both, average dS/dN ratio and codon dN and dS
were calculated with the SNAP web utility (http://hiv-web.lanl.
gov/content/hiv-db/SNAP/WEBSNAP/SNAP.html). Amino
acid entropy was calculated with BioEdit v7.0.5 software.
Recombination analysis
To determine whether recombination events had been
involved in the evolution of Spanish IBV isolates, and to
identify putative recombination breakpoints in the S1 gene, RDP
v2.0 software was used (Martin et al., 2005). Only Spanish field
isolates were included in the study because the objective was to
investigate the extent of recombination events in field. All field
Spanish isolates were aligned using ClustalW program imple-
mented in BioEdit v7.0.5 package. Then, six methods imple-
mented in the RDP v2.0 software package, including RDP,
Bootscan, GENECONV, Maxchi, Chimaera and SiScan were
employed to identify recombinant breakpoints (Gibbs et al.,
2000; Padidam et al., 1999; Posada, 2002; Salminen et al.,
1995). General settings used for all methods were as follows:
window size=20, highest acceptable P value=0.001 and
Bonferroni correction. Only recombination breakpoints detected
by more than three methods were considered. Also, once poten-
tial recombination events were identified, sequence alignment
was split at that point and phylogenetic analysis of the two
regions was performed to evaluate conflicting evolutionary
histories of both regions. Phylogenetic trees were constructed by
using a maximum parsimony method with 1000 bootstraps
(Kumar et al., 2004). Same methods and software have been
previously used in recombination studies with SARS (Zhang
et al., 2005).
Cross-VN analysis
To determine the antigenic relationships among the field
Spanish isolates Spain/99/319 and Spain/99/325 and IBV
reference strains M41, D274, 4/91, D1466 and Italy 02,
reciprocal beta VN assays (diluted-serum constant-virus) were
performed as described by Thayer and Beard (Thayer and Beard,
1998). Four-fold serial dilutions of each antiserum, and 100
EID50 0.1 ml
−1 of each virus were used. Antiserum, virus andnegative controls were carried out in each assay. Endpoint titres
were calculated by the Reed and Müench method (Villegas,
1998). TheVN titres against homologous and heterologous virus
were used to calculate the antigenic relatedness (r-values) by the
formula of Archetti and Horsfall (Archetti and Horsfall, 1950).
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